TITLE

Rationale and methods of the cardiometabolic valencian study (escarval-risk) for validation of risk scales in mediterranean patients with hypertension, diabetes or dyslipidemia

AUTHOR(S)

Gil-Guillen, Vicente; Orozco-Beltran, Domingo; Redon, Josep; Pita-Fernandez, Salvador; Navarro-Pérez, Jorge; Pallares, Vicente; Valls, Francisco; Fluixa, Carlos; Fernandez, Antonio; Martin-Moreno, Jose M; Pascual-de-la-Torre, Manuel; Trillo, Jose L.; Durazo-Arvizu, Ramon; Cooper, Richard; Hermenegildo, Marta; Rosado, Luis

PUB. DATE

January 2010

SOURCE

BMC Public Health;2010, Vol. 10 Issue 1, p717

SOURCE TYPE

Academic Journal

DOC. TYPE

Article

ABSTRACT

Background: The Escarval-Risk study aims to validate cardiovascular risk scales in patients with hypertension, diabetes or dyslipidemia living in the Valencia Community, a European Mediterranean region, based on data from an electronic health recording system comparing predicted events with observed during 5 years follow-up study. Methods/Design: A cohort prospective 5 years follow-up study has been designed including 25000 patients with hypertension, diabetes and/or dyslipidemia attended in usual clinical practice. All information is registered in a unique electronic health recording system (ABUCASIS) that is the usual way to register clinical practice in the Valencian Health System (primary and secondary care). The system covers about 95% of population (near 5 million people). The system is linked with database of mortality register, hospital withdrawals, prescriptions and assurance databases in which each individual have a unique identification number. Diagnoses in clinical practice are always registered based on IDC-9. Occurrence of CV disease was the main outcomes of interest. Risk survival analysis methods will be applied to estimate the cumulative incidence of developing CV events over time. Discussion: The Escarval-Risk study will provide information to validate different cardiovascular risk scales in patients with hypertension, diabetes or dyslipidemia from a low risk Mediterranean Region, the Valencia Community.

ACCESSION #

57226909

 

Related Articles

• ASSOCIAÇÃO ENTRE HIPERTENSÃO ARTERIAL E DIABETES EM CENTRO DE SAÚDE DA FAMÍLIA. Da Silva, Daniele Braz; De Souza, Tereza Alves; Dos Santos, Célia Maria; Jucá, Mércia Marques; Moreira, Thereza Maria Magalhães; Frota, Mirna Albuquerque; Vasconcelos, Silvânia Maria Mendes // Revista Brasileira em Promoção da Saúde;ene2011, Vol. 24 Issue 1, p16 

  Objective: To describe the clinical characteristics of patients with hypertension treated in a health unit and its association with diabetes, relating to sex and age. Methods: We conducted this quantitative and documentary research with 297 registered users in the Plan of Reorganization of Care...

• Microalbuminuria in hypertension is not a determinant of insulin resistance. Toft, Ingrid; Bønaa, Kaare H.; Eikrem, Jorunn; Bendiksen, Åse Lund; Iversen, Hege; Jenssen, Trond // Kidney International;Apr2002, Vol. 61 Issue 4, p1445 

  Background. Microalbuminuria (MA) clusters with metabolic derangements linked to the insulin resistance syndrome, and is associated with increased risk of cardiovascular disease in both diabetes and hypertension. This study questioned if MA, reflecting endothelial damage, is directly linked to...

• Individualizing Targets and Tactics for High-Risk Patients With Type 2 Diabetes. Riddle, Matthew C.; Karl, Diane M. // Diabetes Care;Oct2012, Vol. 35 Issue 10, p2100 

  This article summarizes the original findings of studies on cardiovascular risk in type 2 diabetes mellitus. These include the Action to Control Cardiovascular Risk in Diabetes (ACCORD), the Action in Diabetes and Vascular Disease: Preterax and Diamacron MR Controlled Evaluation (ADVANCE) and...

• Community-Based Lifestyle Modification of Cardiovascular Disease Risks in Middle-Aged Japanese: A 27-Month Update. Fujii, H.; Muto, T.; Haruyama, Y.; Nakade, M.; Kobayashi, E.; Ishisaki, K.; Yamasaki, A. // Tohoku Journal of Experimental Medicine;Apr2010, Vol. 220 Issue 4, p307 

  Lifestyle modification is the cornerstone of preventive management for people with cardiovascular disease risks, such as obesity, hypertension, dyslipidemia and diabetes. This study investigated the effect of a 27-month community-based lifestyle intervention on the reduction of cardiovascular...

• Knowledge of Hypertension and other Risk Factors for Heart Disease among Yoruba Rural Southwestern Nigerian Population. Oladapo, O. O.; Salako, L.; Sadiq, L.; Soyinka, K.; Falase, A. O. // British Journal of Medicine & Medical Research;Oct-Dec2013, Vol. 3 Issue 4, p993 

  Background and Objectives: There is paucity of reliable information on knowledge about hypertension and cardiovascular disease (CVD) risk factors in rural southwestern Nigeria. This study assessed the level of awareness, basic knowledge and management of hypertension and CV risk factors among...

• Detection of cardiovascular risk factors by indices of obesity obtained from anthropometry and dual-energy X-ray absorptiometry in Japanese individuals. Ito, H; Nakasuga, K; Ohshima, A; Maruyama, T; Kaji, Y; Harada, M; Fukunaga, M; Jingu, S; Sakamoto, M // International Journal of Obesity & Related Metabolic Disorders;Feb2003, Vol. 27 Issue 2, p232 

  OBJECTIVE:: To determine the cut-off points of indices of obesity for detecting hypertension, dyslipidemia and diabetes mellitus in Japanese individuals. DESIGN:: Cross-sectional study. SUBJECTS:: A total of 2728 Japanese individuals (768 males and 1960 females, aged 20–79 y) who attended...

• Comparison of microalbuminuria with hs-CRP and low density lipoprotein levels in nondiabetic, nonhypertensive myocardial infarction patients. Manjunatha Goud, B. K.; Nayal, Bhavna; Devi, Oinam S.; Devaki, R. N.; Avinash, S. S.; Satisha, T. G.; Raghuveer, C. V. // Journal of Cardiovascular Disease Research (Medknow Publications;Oct-Dec2012, Vol. 3 Issue 4, p287 

  Introduction: Microalbuminuria (MA), defined as urine albumin to urine creatinine ratio (UACR) of 30 to 300 mg/G of creatinine, is an established risk factor for cardiovascular morbidity and mortality and for endstage renal disease in individuals with an adverse cardiovascular risk profile such...

• Metabolic syndrome in the Middle East. Sliem, Hamdy Ahmed; Ahmed, Seham; Nemr, Nader; El-Sherif, Iman // Indian Journal of Endocrinology & Metabolism;Jan2012, Vol. 16 Issue 1, p67 

  Metabolic syndrome (MS) is a combination of medical disorders that, in concert, increase the risk of developing cardiovascular disease and diabetes. It affects about one in four people in the Middle East, and prevalence increases with age. The aim of current review is to discuss the prevalence...

• Trends in Cardiovascular Disease Risk Factors in People with and without Diabetes Mellitus: A Middle Eastern Cohort Study. Jahangiri-Noudeh, Younes; Akbarpour, Samaneh; Lotfaliany, Mojtaba; Zafari, Neda; Khalili, Davood; Tohidi, Maryam; Mansournia, Mohammad Ali; Azizi, Fereidoun; Hadaegh, Farzad // PLoS ONE;Dec2014, Vol. 9 Issue 12, p1 

  Aims/Hypothesis: To investigate secular trends in cardiovascular disease (CVD) risk factors during a decade of follow-up in a Middle Eastern cohort, and to compare observed trends between diabetic and non-diabetic populations. Methods: In a population of 6181 participants (2622 males and 3559...

Read the Article